Evidence map›Paper›PMID 36253346›Full record

ArticleNature communications2022

Comprehensive and clinically accurate head and neck cancer organs-at-risk delineation on a multi-institutional study.

Xianghua Ye, Dazhou Guo, Jia Ge, Senxiang Yan, Yi Xin, Yuchen Song, Yongheng Yan, Bing-Shen Huang, Tsung-Min Hung, Zhuotun Zhu and 16 more

Abstract readMulticenter Study
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Prevalence of cancer-related cognitive impairment among patients with nasopharyngeal carcinoma: a cross-sectional study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Adaptive Region-Specific Loss for Improved Medical Image Segmentation.IEEE transactions on pattern analysis and machine intelligence · 2023
    Article
  16. Federated Multi-Organ Segmentation With Inconsistent Labels.IEEE transactions on medical imaging · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Xianghua Ye *Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Dazhou Guo *DAMO Academy, Alibaba Group, New York, NY, USA.
Jia Ge *Department of Radiation Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Senxiang YanDepartment of Radiation Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Yi XinPing An Technology, Shenzhen, China.
Yuchen SongDepartment of Radiation Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Yongheng YanDepartment of Radiation Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Bing-Shen HuangDepartment of Radiation Oncology, Chang Gung Memorial Hospital, Linkou, Taiwan, ROC.
Tsung-Min HungDepartment of Radiation Oncology, Chang Gung Memorial Hospital, Linkou, Taiwan, ROC.
Zhuotun ZhuDepartment of Computer Science, Johns Hopkins University, Baltimore, MD, USA.ORCID 0000-0002-1257-4605
Ling PengDepartment of Respiratory Disease, Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang, China.ORCID 0000-0002-1359-4982
Yanping RenDepartment of Radiation Oncology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Rui LiuDepartment of Radiation Oncology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an, China.
Gong ZhangDepartment of Radiation Oncology, People's Hospital of Shanxi Province, Shanxi, China.
Mengyuan MaoDepartment of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Xiaohua ChenDepartment of Radiation Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, China.
Zhongjie LuDepartment of Radiation Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Wenxiang LiDepartment of Radiation Oncology, The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
Yuzhen ChenDepartment of Radiation Oncology, Chang Gung Memorial Hospital, Linkou, Taiwan, ROC.
Lingyun HuangPing An Technology, Shenzhen, China.
Jing XiaoPing An Technology, Shenzhen, China.ORCID 0000-0001-9615-4749
Adam P HarrisonQ Bio Inc, San Carlos, CA, USA.ORCID 0000-0003-3315-1772
Le LuDAMO Academy, Alibaba Group, New York, NY, USA.ORCID 0000-0002-6799-9416
Chien-Yu LinDepartment of Radiation Oncology, Chang Gung Memorial Hospital, Linkou, Taiwan, ROC. qqvirus@cgmh.org.tw.
Dakai JinDAMO Academy, Alibaba Group, New York, NY, USA. dakai.jin@gmail.com.ORCID 0000-0002-4806-2943
Tsung-Ying HoDepartment of Nuclear Medicine, Chang Gung Memorial Hospital, Linkou, Taiwan, ROC. tyho@cgmh.org.tw.ORCID 0000-0002-8468-2226

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Accurate organ-at-risk (OAR) segmentation is critical to reduce radiotherapy complications. Consensus guidelines recommend delineating over 40 OARs in the head-and-neck (H&N). However, prohibitive labor costs cause most institutions to delineate a substantially smaller subset of OARs, neglecting the dose distributions of other OARs. Here, we present an automated and highly effective stratified OAR segmentation (SOARS) system using deep learning that precisely delineates a comprehensive set of 42 H&N OARs. We train SOARS using 176 patients from an internal institution and independently evaluate it on 1327 external patients across six different institutions. It consistently outperforms other state-of-the-art methods by at least 3-5% in Dice score for each institutional evaluation (up to 36% relative distance error reduction). Crucially, multi-user studies demonstrate that 98% of SOARS predictions need only minor or no revisions to achieve clinical acceptance (reducing workloads by 90%). Moreover, segmentation and dosimetric accuracy are within or smaller than the inter-user variation.

Indexed as

Head and Neck NeoplasmsOrgans at RiskHumansImage Processing, Computer-AssistedNeckRadiometry

Identifiers

PMID36253346
PMCPMC9576793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.